메뉴 건너뛰기




Volumn 25, Issue 2 SUPPL. 1, 2009, Pages

Clinical Challenges: Chemotherapy-Induced Peripheral Neuropathy

(1)  Paice, Judith A a  

a NONE

Author keywords

chemotherapy; chemotherapy induced peripheral neuropathy; Pain

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT;

EID: 65549086199     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2009.03.013     Document Type: Article
Times cited : (35)

References (58)
  • 1
    • 0002694436 scopus 로고    scopus 로고
    • The epidemiology and natural history of herpes zoster and postherpetic neuralgia
    • Watson C.P.N. (Ed), Elsevier, Amsterdam
    • Dworkin R.H., and Schmader K.E. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson C.P.N. (Ed). Herpes zoster and postherpetic neuralgia. 2nd ed (2001), Elsevier, Amsterdam 39-65
    • (2001) Herpes zoster and postherpetic neuralgia. 2nd ed , pp. 39-65
    • Dworkin, R.H.1    Schmader, K.E.2
  • 2
  • 3
    • 33646586688 scopus 로고    scopus 로고
    • Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction
    • Flatters S.J., and Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122 (2006) 245-257
    • (2006) Pain , vol.122 , pp. 245-257
    • Flatters, S.J.1    Bennett, G.J.2
  • 4
    • 33746665258 scopus 로고    scopus 로고
    • Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat
    • Jimenez-Andrade J.M., Peters C.M., Mejia N.A., et al. Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury following intravenous administration of paclitaxel in the rat. Neurosci Lett 405 (2006) 62-67
    • (2006) Neurosci Lett , vol.405 , pp. 62-67
    • Jimenez-Andrade, J.M.1    Peters, C.M.2    Mejia, N.A.3
  • 5
    • 32244438054 scopus 로고    scopus 로고
    • Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
    • Hausheer F.H., Schilsky R.L., Bain S., et al. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33 (2006) 15-49
    • (2006) Semin Oncol , vol.33 , pp. 15-49
    • Hausheer, F.H.1    Schilsky, R.L.2    Bain, S.3
  • 6
    • 0041386046 scopus 로고    scopus 로고
    • Development of a Neuropathic Pain Questionnaire
    • Krause S.J., and Backonja M.-M. Development of a Neuropathic Pain Questionnaire. Clin J Pain 19 (2003) 306-314
    • (2003) Clin J Pain , vol.19 , pp. 306-314
    • Krause, S.J.1    Backonja, M.-M.2
  • 7
    • 0043073211 scopus 로고    scopus 로고
    • Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane)
    • Cella D., Peterman A., Hudgens S., Webster K., and Socinski M.A. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer 98 (2003) 822-831
    • (2003) Cancer , vol.98 , pp. 822-831
    • Cella, D.1    Peterman, A.2    Hudgens, S.3    Webster, K.4    Socinski, M.A.5
  • 8
    • 21144457498 scopus 로고    scopus 로고
    • The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20
    • Postma T.J., Aaronson N.K., Heimans J.J., et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer 41 (2005) 1135-1139
    • (2005) Eur J Cancer , vol.41 , pp. 1135-1139
    • Postma, T.J.1    Aaronson, N.K.2    Heimans, J.J.3
  • 9
    • 0031823939 scopus 로고    scopus 로고
    • Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy
    • Postma T.J., Heimans J.J., Muller M.J., et al. Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9 (1998) 739-744
    • (1998) Ann Oncol , vol.9 , pp. 739-744
    • Postma, T.J.1    Heimans, J.J.2    Muller, M.J.3
  • 10
    • 0028270476 scopus 로고
    • Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies
    • Chaudhry V., Rowinsky E.K., Sartorius S.E., et al. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35 (1994) 304-311
    • (1994) Ann Neurol , vol.35 , pp. 304-311
    • Chaudhry, V.1    Rowinsky, E.K.2    Sartorius, S.E.3
  • 11
    • 0030839691 scopus 로고    scopus 로고
    • Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
    • Forsyth P.A., Balmaceda C., Peterson K., et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol 35 (1997) 47-53
    • (1997) J Neurooncol , vol.35 , pp. 47-53
    • Forsyth, P.A.1    Balmaceda, C.2    Peterson, K.3
  • 12
    • 1842735565 scopus 로고    scopus 로고
    • Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
    • Dougherty P.M., Cata J.P., Cordella J.V., et al. Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain 109 (2004) 132-142
    • (2004) Pain , vol.109 , pp. 132-142
    • Dougherty, P.M.1    Cata, J.P.2    Cordella, J.V.3
  • 13
    • 22844448647 scopus 로고    scopus 로고
    • Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?
    • Argyriou A.A., Polychronopoulos P., Koutras A., et al. Peripheral neuropathy induced by administration of cisplatin- and paclitaxel-based chemotherapy. Could it be predicted?. Support Care Cancer 13 (2005) 647-651
    • (2005) Support Care Cancer , vol.13 , pp. 647-651
    • Argyriou, A.A.1    Polychronopoulos, P.2    Koutras, A.3
  • 14
    • 33644980892 scopus 로고    scopus 로고
    • Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy
    • Flatters S.J., Xiao W.H., and Bennett G.J. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 397 (2006) 219-223
    • (2006) Neurosci Lett , vol.397 , pp. 219-223
    • Flatters, S.J.1    Xiao, W.H.2    Bennett, G.J.3
  • 15
    • 0024513342 scopus 로고
    • Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats
    • Fernandez E., Pallini R., Gangitano C., et al. Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats. Neurol Res 11 (1989) 57-62
    • (1989) Neurol Res , vol.11 , pp. 57-62
    • Fernandez, E.1    Pallini, R.2    Gangitano, C.3
  • 16
    • 1842786064 scopus 로고    scopus 로고
    • Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy
    • Flatters S.J., and Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109 (2004) 150-161
    • (2004) Pain , vol.109 , pp. 150-161
    • Flatters, S.J.1    Bennett, G.J.2
  • 17
    • 45949131693 scopus 로고    scopus 로고
    • Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies
    • Wolf S., Barton D., Kottschade L., et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44 (2008) 1507-1515
    • (2008) Eur J Cancer , vol.44 , pp. 1507-1515
    • Wolf, S.1    Barton, D.2    Kottschade, L.3
  • 18
    • 0037366026 scopus 로고    scopus 로고
    • Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
    • Pace A., Savarese A., Picardo M., et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 21 (2003) 927-931
    • (2003) J Clin Oncol , vol.21 , pp. 927-931
    • Pace, A.1    Savarese, A.2    Picardo, M.3
  • 19
    • 33845454129 scopus 로고    scopus 로고
    • A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results
    • Argyriou A.A., Chroni E., Koutras A., et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support Care Cancer 14 (2006) 1134-1140
    • (2006) Support Care Cancer , vol.14 , pp. 1134-1140
    • Argyriou, A.A.1    Chroni, E.2    Koutras, A.3
  • 20
    • 46049107024 scopus 로고    scopus 로고
    • Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity [abstr 9114]
    • (18S)
    • Pace A., Carpano S., Galie E., et al. Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity [abstr 9114]. J Clin Oncol (2007) 25 (18S)
    • (2007) J Clin Oncol , pp. 25
    • Pace, A.1    Carpano, S.2    Galie, E.3
  • 21
    • 65549171128 scopus 로고    scopus 로고
    • A phase III randomized, placebo-controlled, double-blind sutdy of intravenous calcium/magnesium to prevent oxaliplatin-induced sensory neurotoxicity, N04C7
    • Nikcevich DA, Grothey A, Sloan JA, et al. A phase III randomized, placebo-controlled, double-blind sutdy of intravenous calcium/magnesium to prevent oxaliplatin-induced sensory neurotoxicity, N04C7. J Clin Oncol 2008 ASCO Annual Meeting Proceedings (Abstract 280).
    • J Clin Oncol 2008 ASCO Annual Meeting Proceedings (Abstract , vol.280
    • Nikcevich, D.A.1    Grothey, A.2    Sloan, J.A.3
  • 22
    • 34147102323 scopus 로고    scopus 로고
    • Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients
    • Wang W.S., Lin J.K., Lin T.C., et al. Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 12 (2007) 312-319
    • (2007) Oncologist , vol.12 , pp. 312-319
    • Wang, W.S.1    Lin, J.K.2    Lin, T.C.3
  • 23
    • 0037102328 scopus 로고    scopus 로고
    • Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial
    • Cascinu S., Catalano V., Cordella L., et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 20 (2002) 3478-3483
    • (2002) J Clin Oncol , vol.20 , pp. 3478-3483
    • Cascinu, S.1    Catalano, V.2    Cordella, L.3
  • 24
    • 0031158107 scopus 로고    scopus 로고
    • Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial
    • Smyth J.F., Bowman A., Perren T., et al. Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomized trial. Ann Oncol 8 (1997) 569-573
    • (1997) Ann Oncol , vol.8 , pp. 569-573
    • Smyth, J.F.1    Bowman, A.2    Perren, T.3
  • 25
    • 0028815902 scopus 로고
    • Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial
    • Cascinu S., Cordella L., Del Ferro E., et al. Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. J Clin Oncol 13 (1995) 26-32
    • (1995) J Clin Oncol , vol.13 , pp. 26-32
    • Cascinu, S.1    Cordella, L.2    Del Ferro, E.3
  • 26
    • 33646464224 scopus 로고    scopus 로고
    • N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data
    • Lin P.C., Lee M.Y., Wang W.S., et al. N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Support Care Cancer 14 (2006) 484-487
    • (2006) Support Care Cancer , vol.14 , pp. 484-487
    • Lin, P.C.1    Lee, M.Y.2    Wang, W.S.3
  • 27
    • 33845915641 scopus 로고    scopus 로고
    • Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy
    • Argyriou A.A., Chroni E., Polychronopoulos P., et al. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy. Neurology 67 (2006) 2253-2255
    • (2006) Neurology , vol.67 , pp. 2253-2255
    • Argyriou, A.A.1    Chroni, E.2    Polychronopoulos, P.3
  • 28
    • 33750904099 scopus 로고    scopus 로고
    • Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first line treatment of patients (pts) with metastatic colorectal cancer (MCRC)
    • (abstract 229)
    • Cassidy J., Bjarnason G., Hickish T., et al. Randomized double blind (DB) placebo (Plcb) controlled phase III study assessing the efficacy of xaliproden (X) in reducing the cumulative peripheral sensory neuropathy (PSN) induced by the oxaliplatin (Ox) and 5-FU/LV combination (FOLFOX4) in first line treatment of patients (pts) with metastatic colorectal cancer (MCRC). J Clin Oncol 24 suppl (2006) 3507 (abstract 229)
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL , pp. 3507
    • Cassidy, J.1    Bjarnason, G.2    Hickish, T.3
  • 29
    • 0036299151 scopus 로고    scopus 로고
    • Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
    • Hammack J.E., Michalak J.C., Loprinzi C.L., et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain 98 (2002) 195-203
    • (2002) Pain , vol.98 , pp. 195-203
    • Hammack, J.E.1    Michalak, J.C.2    Loprinzi, C.L.3
  • 30
    • 37349006917 scopus 로고    scopus 로고
    • Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms
    • Kautio A.L., Haanpää M., Saarto T., et al. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J Pain Symptom Manage 35 (2008) 31-39
    • (2008) J Pain Symptom Manage , vol.35 , pp. 31-39
    • Kautio, A.L.1    Haanpää, M.2    Saarto, T.3
  • 31
    • 35648929958 scopus 로고    scopus 로고
    • Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)
    • Rao R.D., Michalak J.C., Sloan J.A., et al. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer 110 (2007) 2110-2118
    • (2007) Cancer , vol.110 , pp. 2110-2118
    • Rao, R.D.1    Michalak, J.C.2    Sloan, J.A.3
  • 32
    • 46049110377 scopus 로고    scopus 로고
    • Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3
    • Rao R.D., Flynn P.J., Sloan J.A., et al. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer 112 (2008) 2802-2808
    • (2008) Cancer , vol.112 , pp. 2802-2808
    • Rao, R.D.1    Flynn, P.J.2    Sloan, J.A.3
  • 33
    • 21744443122 scopus 로고    scopus 로고
    • Clinical management of oxaliplatin-associated neurotoxicity
    • Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer 1 suppl 5 (2005) S38-S46
    • (2005) Clin Colorectal Cancer , vol.1 , Issue.SUPPL. 5
    • Grothey, A.1
  • 34
    • 11444259306 scopus 로고    scopus 로고
    • Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial
    • Argyriou A.A., Chroni E., Koutras A., et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 64 (2005) 26-31
    • (2005) Neurology , vol.64 , pp. 26-31
    • Argyriou, A.A.1    Chroni, E.2    Koutras, A.3
  • 35
    • 3042523914 scopus 로고    scopus 로고
    • Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer
    • Gamelin L., Boisdron-Celle M., Delva R., et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-fluorouracil and leucovorin for advanced colorectal cancer. Clin Cancer Res 10 (2004) 4055-4061
    • (2004) Clin Cancer Res , vol.10 , pp. 4055-4061
    • Gamelin, L.1    Boisdron-Celle, M.2    Delva, R.3
  • 36
    • 34548544244 scopus 로고    scopus 로고
    • Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity
    • Hochster H.S., Grothey A., and Childs B.H. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity. J Clin Oncol 25 (2007) 4028-4029
    • (2007) J Clin Oncol , vol.25 , pp. 4028-4029
    • Hochster, H.S.1    Grothey, A.2    Childs, B.H.3
  • 37
    • 33644843853 scopus 로고    scopus 로고
    • OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer-a GERCOR study
    • Tournigand C., Cervantes A., Figer A., et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer-a GERCOR study. J Clin Oncol 24 (2006) 394-400
    • (2006) J Clin Oncol , vol.24 , pp. 394-400
    • Tournigand, C.1    Cervantes, A.2    Figer, A.3
  • 38
    • 35748943212 scopus 로고    scopus 로고
    • Pharmacologic management of neuropathic pain: evidence-based recommendations
    • Dworkin R.H., O'Connor A.B., Backonja M., et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132 (2007) 237-251
    • (2007) Pain , vol.132 , pp. 237-251
    • Dworkin, R.H.1    O'Connor, A.B.2    Backonja, M.3
  • 39
    • 0037468691 scopus 로고    scopus 로고
    • Oral opioid therapy for chronic peripheral and central neuropathic pain
    • Rowbotham M.C., Twilling L., Davies P.S., et al. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 348 (2003) 1223-1232
    • (2003) N Engl J Med , vol.348 , pp. 1223-1232
    • Rowbotham, M.C.1    Twilling, L.2    Davies, P.S.3
  • 40
    • 42349085789 scopus 로고    scopus 로고
    • Current developments in opioid therapy for management of cancer pain
    • de Leon-Casasola O.A. Current developments in opioid therapy for management of cancer pain. Clin J Pain 24 suppl 10 (2008) S3-S7
    • (2008) Clin J Pain , vol.24 , Issue.SUPPL. 10
    • de Leon-Casasola, O.A.1
  • 41
    • 3042595723 scopus 로고    scopus 로고
    • Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study
    • Gabrail N.Y., Dvergsten C., and Ahdieh H. Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study. Curr Med Res Opin 20 (2004) 911-918
    • (2004) Curr Med Res Opin , vol.20 , pp. 911-918
    • Gabrail, N.Y.1    Dvergsten, C.2    Ahdieh, H.3
  • 42
    • 48449090565 scopus 로고    scopus 로고
    • Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies
    • Xiao W., Naso L., and Bennett G.J. Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med 9 (2008) 505-517
    • (2008) Pain Med , vol.9 , pp. 505-517
    • Xiao, W.1    Naso, L.2    Bennett, G.J.3
  • 43
  • 44
    • 56049123409 scopus 로고    scopus 로고
    • The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
    • Waddell D.S., Baehr L.M., van den Brandt J., et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 295 (2008) E785-E797
    • (2008) Am J Physiol Endocrinol Metab , vol.295
    • Waddell, D.S.1    Baehr, L.M.2    van den Brandt, J.3
  • 45
    • 34548191071 scopus 로고    scopus 로고
    • Role of glucocorticoids in the molecular regulation of muscle wasting
    • Menconi M., Fareed M., O'Neal P., et al. Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35 suppl (2007) S602-S608
    • (2007) Crit Care Med , vol.35 , Issue.SUPPL
    • Menconi, M.1    Fareed, M.2    O'Neal, P.3
  • 46
    • 37249020448 scopus 로고    scopus 로고
    • Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer
    • Saif M.W., and Hashmi S. Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer. Cancer Chemother Pharmacol 61 (2008) 349-354
    • (2008) Cancer Chemother Pharmacol , vol.61 , pp. 349-354
    • Saif, M.W.1    Hashmi, S.2
  • 47
    • 33746158512 scopus 로고    scopus 로고
    • Risk of aplastic anemia in patients using antiepileptic drugs
    • Handoko K.B., Souverein P.C., van Staa T.P., et al. Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia 47 (2006) 1232-1236
    • (2006) Epilepsia , vol.47 , pp. 1232-1236
    • Handoko, K.B.1    Souverein, P.C.2    van Staa, T.P.3
  • 48
    • 53549124403 scopus 로고    scopus 로고
    • Hepatotoxicity associated with antiepileptic drugs
    • Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 118 (2008) 281-290
    • (2008) Acta Neurol Scand , vol.118 , pp. 281-290
    • Bjornsson, E.1
  • 49
    • 18844420343 scopus 로고    scopus 로고
    • Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy
    • Durand J.P., Alexandre J., Guillevin L., et al. Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy. Anticancer Drugs 16 (2005) 587-591
    • (2005) Anticancer Drugs , vol.16 , pp. 587-591
    • Durand, J.P.1    Alexandre, J.2    Guillevin, L.3
  • 50
    • 0037056091 scopus 로고    scopus 로고
    • Use of anticonvulsants for treatment of neuropathic pain
    • Backonja M.M. Use of anticonvulsants for treatment of neuropathic pain. Neurology 59 suppl 2 (2002) S14-S17
    • (2002) Neurology , vol.59 , Issue.SUPPL. 2
    • Backonja, M.M.1
  • 51
    • 0037318162 scopus 로고    scopus 로고
    • Antidepressants for chronic neuropathic pain
    • Reisner L. Antidepressants for chronic neuropathic pain. Curr Pain Headache Rep 7 (2003) 24-33
    • (2003) Curr Pain Headache Rep , vol.7 , pp. 24-33
    • Reisner, L.1
  • 52
    • 48449102484 scopus 로고    scopus 로고
    • Anticholinergic activity of 107 medications commonly used by older adults
    • Chew M.L., Mulsant B.H., Pollock B.G., et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 56 (2008) 1333-1341
    • (2008) J Am Geriatr Soc , vol.56 , pp. 1333-1341
    • Chew, M.L.1    Mulsant, B.H.2    Pollock, B.G.3
  • 53
    • 35848958367 scopus 로고    scopus 로고
    • Antidepressant agents for the treatment of chronic pain and depression
    • Jann M.W., and Slade J.H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 27 (2007) 1571-1587
    • (2007) Pharmacotherapy , vol.27 , pp. 1571-1587
    • Jann, M.W.1    Slade, J.H.2
  • 54
    • 33747303833 scopus 로고    scopus 로고
    • A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study
    • Nalamachu S., Crockett R.S., Gammaitoni A.R., et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group study. MedGenMed 8 (2006) 33-44
    • (2006) MedGenMed , vol.8 , pp. 33-44
    • Nalamachu, S.1    Crockett, R.S.2    Gammaitoni, A.R.3
  • 55
    • 0032954053 scopus 로고    scopus 로고
    • Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study
    • Galer B.S., Rowbotham M.C., Perander J., et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80 (1999) 533-538
    • (1999) Pain , vol.80 , pp. 533-538
    • Galer, B.S.1    Rowbotham, M.C.2    Perander, J.3
  • 56
    • 2942532905 scopus 로고    scopus 로고
    • Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy
    • Barbano R.L., Herrmann D.N., Hart-Gouleau S., et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 61 (2004) 914-918
    • (2004) Arch Neurol , vol.61 , pp. 914-918
    • Barbano, R.L.1    Herrmann, D.N.2    Hart-Gouleau, S.3
  • 57
    • 0034237501 scopus 로고    scopus 로고
    • Systemic lidocaine for neuropathic pain relief
    • Mao J., and Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain 87 (2000) 7-17
    • (2000) Pain , vol.87 , pp. 7-17
    • Mao, J.1    Chen, L.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.